Seer to Report First Quarter 2025 Financial Results on May 13, 2025

Company Overview - Seer, Inc. is a leading life sciences company focused on commercializing a new platform for proteomics [1][3] - The company has developed the Proteograph™ Product Suite, which includes engineered nanoparticles, consumables, automation instrumentation, and software for deep proteomic analysis [3] Financial Announcement - Seer, Inc. will report its financial results for the first quarter of 2025 on May 13, 2025 [1] - A conference call will be webcasted starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time [1][2] Product Details - The Proteograph Product Suite is designed for efficient and easy use, allowing for unbiased proteomic analysis at scale within hours [3] - The product is intended for research use only and is not meant for diagnostic procedures [3]